Maven Securities LTD Athira Pharma, Inc. Transaction History

Maven Securities LTD

  • $1.61 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$9.15 - $11.09 $514,888 - $624,056
-56,272 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$10.24 - $20.87 $576,225 - $1.17 Million
56,272 New
56,272 $585,000
Q4 2020

Feb 12, 2021
SELL
$16.48 - $34.3 $206,000 - $428,749
-12,500 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$16.02 - $18.46 $200,250 - $230,750
12,500 New
12,500 $207,000

Others Institutions Holding ATHA

# of Institutions
83
Shares Held
22.3M
Call Options Held
77.1K
Put Options Held
42.4K
View Full List

About Athira Pharma, Inc.

ATHA Quotes by TradingView
  • Ticker ATHA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,817,700
  • Market Cap $96.4M
  • Description
  • Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...
More about ATHA
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email